Annual EPS
$2.09$0.67+46.73%
Summary
- Current Value
- As of today, DXCM annual EPS is $2.09, up +46.73% on
- Historical Performance
- DXCM annual EPS is up +161.81% over the past 3 years, up +65.10% over the past 5 years
- All-Time High Comparison
- DXCM annual EPS is currently at its all-time high
- 3-Year Low Comparison
- DXCM annual EPS is +161.81% above its 3-year low of $0.80 reached on an earlier date
- Sector Comparison
- DXCM annual EPS is higher than 90.48% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DXCM annual EPS at $2.70, +29.25% higher than the current value
- Upcoming Earnings
- The next annual earnings release for DXCM is on
EPS Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $2.09 | +46.7% | +161.8% | +65.1% | +961.6% | |
| Quarterly EPS | $0.72 | +2.6% | +149.0% | +244.6% | +1543.0% | |
| TTM EPS | $2.55 | +42.0% | +182.6% | +83.5% | +1646.3% | |
| Price | $81.98 | +36.3% | -21.9% | -49.4% | +4518.6% | |
| Annual Revenue | $4.66B | +15.6% | +60.2% | +142.0% | +9486.5% | |
| PE Ratio | 32.13 | -4.1% | -72.4% | -72.4% | – | |
| Annual Net Income | $836.30M | +45.1% | +145.1% | +69.4% | +1615.9% | |
| Annual Gross Profit | $2.80B | +15.1% | +49.2% | +118.5% | +10000.0% | |
| Shares Outstanding | 372.95M | -4.4% | -3.5% | -3.8% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.09 | at high | |
| 5Y | $2.09 | at high | |
| All | $2.09 | at high |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.80 | N/A | +161.8% |
| 5Y | $0.51 | +313.1% | |
| All | -$0.59 | +455.7% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.69 | $1.42 | -15.54% | |
| $2.07 | $2.09 | +0.83% | |
| $2.70 | N/A | +29.25% | |
| $3.13 | N/A | +50.03% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
- What is the current annual EPS of DXCM?
- As of today, DXCM annual EPS is $2.09
- What is 1-year change in DXCM annual EPS?
- DXCM annual EPS is up +46.73% year-over-year
- What is 3-year change in DXCM annual EPS?
- DXCM annual EPS is up +161.81% over the past 3 years
- How far is DXCM annual EPS from its all-time high?
- DXCM annual EPS is currently at its all-time high
- How does DXCM annual EPS rank versus sector peers?
- DXCM annual EPS is higher than 90.48% of companies in Healthcare sector
- How does the analyst estimate for DXCM annual EPS compare to its current value?
- Analysts estimate DXCM annual EPS at $2.70, +29.25% higher than the current value
- When is DXCM next annual earnings release?
- The next annual earnings release for DXCM is on
EPS Formula
EPS =
Quarterly EPS
$0.72$0.08+12.23%
Summary
- Current Value
- As of today, DXCM quarterly EPS is $0.72, up +12.23% on
- Historical Performance
- DXCM quarterly EPS is up +2.56% year-over-year, up +148.96% over the past 3 years
- All-Time High Comparison
- DXCM quarterly EPS is currently -15.26% below its historical high of $0.85 set on
- 3-Year Low Comparison
- DXCM quarterly EPS is +171.44% above its 3-year low of $0.27 reached on
- Sector Comparison
- DXCM quarterly EPS is higher than 90.45% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DXCM quarterly EPS at $0.72, -0.62% lower than the current value
- Upcoming Earnings
- The next earnings release for DXCM is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $0.72 | +12.2% | +2.6% | +149.0% | +244.6% | |
| Annual EPS | $2.09 | – | +46.7% | +161.8% | +65.1% | |
| TTM EPS | $2.55 | +0.7% | +42.0% | +182.6% | +83.5% | |
| Price | $81.98 | -8.5% | +36.3% | -21.9% | -49.4% | |
| Quarterly Revenue | $1.34B | +2.8% | +11.2% | +37.9% | +106.8% | |
| PE Ratio | 32.13 | -9.2% | -4.1% | -72.4% | -72.4% | |
| Quarterly Net Income | $275.10M | +10.4% | -3.1% | +127.9% | +215.1% | |
| Quarterly Gross Profit | $864.40M | +4.1% | +15.7% | +39.1% | +105.1% | |
| Shares Outstanding | 372.95M | – | -4.4% | -3.5% | -3.8% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $0.72 | at high | |
| 3Y | $0.72 | at high | |
| 5Y | $0.72 | at high | |
| All | $0.85 | -15.3% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.51 | +41.2% | |
| 3Y | $0.27 | +171.4% | |
| 5Y | -$0.01 | +5366.4% | |
| All | -$0.59 | +222.3% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.61 | $0.64 | +5.91% | |
| $0.67 | $0.72 | +7.05% | |
| $0.72 | N/A | -0.62% | |
| $0.64 | N/A | -11.68% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
- What is the current quarterly EPS of DXCM?
- As of today, DXCM quarterly EPS is $0.72
- What is DXCM quarterly EPS most recent change?
- DXCM quarterly EPS was up +12.23% on September 30, 2026
- What is 1-year change in DXCM quarterly EPS?
- DXCM quarterly EPS is up +2.56% year-over-year
- How far is DXCM quarterly EPS from its all-time high?
- DXCM quarterly EPS is currently -15.26% below its historical high of $0.85 set on December 31, 2020
- How does DXCM quarterly EPS rank versus sector peers?
- DXCM quarterly EPS is higher than 90.45% of companies in Healthcare sector
- How does the analyst estimate for DXCM quarterly EPS compare to its current value?
- Analysts estimate DXCM quarterly EPS at $0.72, -0.62% lower than the current value
- When is DXCM next earnings release?
- The next earnings release for DXCM is on
EPS Formula
EPS =
TTM EPS
$2.55$0.02+0.71%
Summary
- Current Value
- As of today, DXCM TTM EPS is $2.55, up +0.71% on
- Historical Performance
- DXCM TTM EPS is up +42.00% year-over-year, up +182.64% over the past 3 years
- All-Time High Comparison
- DXCM TTM EPS is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM EPS is +182.64% above its 3-year low of $0.90 reached on an earlier date
- Sector Comparison
- DXCM TTM EPS is higher than 90.26% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DXCM TTM EPS at $2.59, +1.60% higher than the current value
- Upcoming Earnings
- The next earnings release for DXCM is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $2.55 | +0.7% | +42.0% | +182.6% | +83.5% | |
| Quarterly EPS | $0.72 | +12.2% | +2.6% | +149.0% | +244.6% | |
| Annual EPS | $2.09 | – | +46.7% | +161.8% | +65.1% | |
| Price | $81.98 | -8.5% | +36.3% | -21.9% | -49.4% | |
| TTM Revenue | $5.10B | +2.7% | +13.0% | +50.0% | +120.1% | |
| PE Ratio | 32.13 | -9.2% | -4.1% | -72.4% | -72.4% | |
| TTM Net Income | $991.00M | -0.9% | +37.5% | +162.9% | +71.6% | |
| TTM Gross Profit | $3.28B | +3.7% | +22.2% | +51.2% | +107.2% | |
| Shares Outstanding | 372.95M | – | -4.4% | -3.5% | -3.8% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.55 | at high | |
| 3Y | $2.55 | at high | |
| 5Y | $2.55 | at high | |
| All | $2.55 | at high |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.80 | N/A | +42.0% |
| 3Y | $0.90 | N/A | +182.6% |
| 5Y | $0.53 | +385.8% | |
| All | -$0.89 | +388.3% |
TTM EPS History
FAQ
- What is the current TTM EPS of DXCM?
- As of today, DXCM TTM EPS is $2.55
- What is DXCM TTM EPS most recent change?
- DXCM TTM EPS was up +0.71% on September 30, 2026
- What is 1-year change in DXCM TTM EPS?
- DXCM TTM EPS is up +42.00% year-over-year
- How far is DXCM TTM EPS from its all-time high?
- DXCM TTM EPS is currently at its all-time high
- How does DXCM TTM EPS rank versus sector peers?
- DXCM TTM EPS is higher than 90.26% of companies in Healthcare sector
- How does the analyst estimate for DXCM TTM EPS compare to its current value?
- Analysts estimate DXCM TTM EPS at $2.59, +1.60% higher than the current value
- When is DXCM next earnings release?
- The next earnings release for DXCM is on
EPS Formula
EPS =
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm
